Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-16,000
Closed -$31K 197
2017
Q1
$31K Buy
16,000
+1,000
+7% +$166K 0.04% 174
2016
Q4
$23K Buy
+15,000
New +$2.26M 0.03% 167
2016
Q3
Sell
-55,000
Closed -$157K 371
2016
Q2
$157K Buy
55,000
+2,100
+4% +$326K 0.13% 118
2016
Q1
$71K Buy
+52,900
New +$7.86M 0.07% 145

Other funds holding AMGN

FT Options's AMGN Position: Q3 2017 in Review

FT Options sold out of Amgen (AMGN) in Q3 2017, closing a stake of 12,082 shares — an estimated $2.08M sold.

FT Options first reported a position in AMGN in Q4 2015 and held it in 2 quarters. The position peaked at $2.08M in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • FT Options reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • FT Options sold 12,082 Amgen shares in Q3 2017, an estimated $2.08M.
  • FT Options first reported a position in Amgen in Q4 2015 and held it in 2 quarters.
  • FT Options's Amgen position peaked at $2.08M in Q2 2017.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.